Zobrazeno 1 - 10
of 27
pro vyhledávání: '"Sara Colomer-Lahiguera"'
Autor:
Nils Graber, Nina Canova, Denise Bryant‐Lukosius, Glenn Robert, Blanca Navarro‐Rodrigo, Lionel Trueb, George Coukos, Manuela Eicher, Tourane Corbière, Sara Colomer‐Lahiguera
Publikováno v:
Health Expectations, Vol 27, Iss 4, Pp n/a-n/a (2024)
Abstract Background Experience‐Based Co‐Design (EBCD) is a multi‐stage participatory action research process which was developed originally to increase patient involvement in service improvement initiatives. This viewpoint article serves as a r
Externí odkaz:
https://doaj.org/article/e5a2fa5990d74831bfb54e5f43fc3ac0
Autor:
Sara Colomer‐Lahiguera, Matthieu Steimer, Ursula Ellis, Manuela Eicher, Margaret Tompson, Tourane Corbière, Kristen R. Haase
Publikováno v:
Cancer Medicine, Vol 12, Iss 14, Pp 15530-15543 (2023)
Abstract Introduction Patient and public involvement (PPI) in research emphasizes the importance of doing research with, rather than for people with lived health/illness experience(s). The purpose of this scoping review is to investigate the breadth
Externí odkaz:
https://doaj.org/article/a30ab795ead948819d8e1e72b6de86ce
Autor:
André Manuel da Silva Lopes, Sara Colomer-Lahiguera, Célia Darnac, Stellio Giacomini, Sébastien Bugeia, Garance Gutknecht, Gilliosa Spurrier-Bernard, Michel Cuendet, Fanny Muet, Veronica Aedo-Lopez, Nuria Mederos, Olivier Michielin, Alfredo Addeo, Sofiya Latifyan, Manuela Eicher
Publikováno v:
JMIR Research Protocols, Vol 12, p e48386 (2023)
BackgroundManagement of severe symptomatic immune-related adverse events (IrAEs) related to immune checkpoint inhibitors (ICIs) can be facilitated by timely detection. As patients face a heterogeneous set of symptoms outside the clinical setting, rem
Externí odkaz:
https://doaj.org/article/7eb558a2a18346f7a7e9ccc15a86392c
Autor:
Manuela Eicher, Massimo Di Maio, George Coukos, Lionel Trueb, Matteo Morotti, Eleonora Ghisoni, Sara Colomer-Lahiguera
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 10, Iss 12 (2022)
Adoptive cell therapies (ACT) have demonstrated promise in the treatment of patients with cancer, leading to long-lasting responses and, in some cases, even cure. Technological advances have brought these individualized therapies closer to reality, e
Externí odkaz:
https://doaj.org/article/9e517d74a1674ea6840acf0cdd210cbf
Autor:
Sara Colomer-Lahiguera, Denise Bryant-Lukosius, Sarah Rietkoetter, Lorraine Martelli, Karin Ribi, Donna Fitzpatrick-Lewis, Diana Sherifali, Angela Orcurto, Rosalyn Juergens, Manuela Eicher
Publikováno v:
Journal of Patient-Reported Outcomes, Vol 4, Iss 1, Pp 1-9 (2020)
Abstract Context Immune-checkpoint inhibitors (ICI) have shown significant benefits for overall survival across various cancer types. Patient-reported outcomes (PROs) are assessed in clinical trials as a measure of efficacy. However, it remains uncle
Externí odkaz:
https://doaj.org/article/ee546c5e033a4c6dab7f30c36e5c21cd
Autor:
Delphine Vuattoux, Sara Colomer-Lahiguera, Pierre-Alain Fernandez, Marine Jequier Gygax, Marie-Louise Choucair, Maja Beck-Popovic, Manuel Diezi, Sabine Manificat, Sofiya Latifyan, Anne-Sylvie Ramelet, Manuela Eicher, Nadia Chabane, Raffaele Renella
Publikováno v:
Frontiers in Oncology, Vol 10 (2021)
Delivering optimal cancer care to children, adolescents and adults with ASD has recently become a healthcare priority and represents a major challenge for all providers involved. In this review, and after consideration of the available evidence, we c
Externí odkaz:
https://doaj.org/article/d2b5562d5f0b488aaf4f059e4df900dc
Autor:
Anne Gerber, André Da Silva Lopes, Natacha Szüts, Michael Simon, Viviane Ribordy‐Baudat, Andreas Ebneter, Claire Perrinjaquet, Marie‐Estelle Gaignard, Delphine Nicodet, Daniel Betticher, Grégoire Bula, Maxime Cote, Michel André Duchosal, Pierre‐André Berret, Pierre‐Yves Dietrich, Caitlin Brennan, Sandy Decosterd, Sandrina Ferreira Nobre, Solange Peters, Reto Koelliker, Françoise Ninane, Marie‐Madlen Jeitziner, Sara Colomer‐Lahiguera, Manuela Eicher
Publikováno v:
Health Science Reports, Vol 3, Iss 2, Pp n/a-n/a (2020)
Abstract Background and aims The occurrence rate of adverse events (AEs) related to care among hospitalized oncology patients in Switzerland remains unknown. The primary objective of this study was to describe, for the first time, the occurrence rate
Externí odkaz:
https://doaj.org/article/d5ae6c013a44450fbe34db168af17ccd
Autor:
André Manuel da Silva Lopes, Sara Colomer-Lahiguera, Célia Darnac, Stellio Giacomini, Sébastien Bugeia, Garance Gutknecht, Gilliosa Spurrier-Bernard, Michel Alain Cuendet, Fanny Muet, Veronica Aedo-Lopez, Nuria Neisy Mederos Alfonso, Olivier Michielin, Alfredo Addeo, Sofiya Latifyan, Manuela Eicher
BACKGROUND Management of severe symptomatic immune-related adverse events (IrAEs) related to immune-checkpoint inhibitors (ICI) can be facilitated by timely detection of these complications. As patients face a heterogeneous set of symptoms outside th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9e06422755d07805ce0301920da1a567
https://doi.org/10.2196/preprints.48386
https://doi.org/10.2196/preprints.48386
Autor:
Sara Colomer-Lahiguera, Tourane Corbière, Frédérique Reeb-Landry, Françoise Ninane, Alfredo Addeo, Manuela Eicher
Publikováno v:
Revue Médicale Suisse. 18:621-625
Autor:
Chantal Arditi, Manuela Eicher, Sara Colomer‐Lahiguera, Christine Bienvenu, Sandro Anchisi, Daniel Betticher, Pierre‐Yves Dietrich, Michel Duchosal, Solange Peters, Isabelle Peytremann‐Bridevaux
Publikováno v:
European journal of cancer care, vol. 31, no. 6, pp. e13705
The objectives were to describe patients' experiences of cancer care in Switzerland and explore the variation of these experiences by type of cancer. The Swiss Cancer Patient Experiences (SCAPE) study was a cross-sectional, multicentre survey conduct